| Tina Powers, RN | |
|
915 6th Ave Ne Apt 301, Buffalo, MN 55313-1862 | |
| (763) 228-5658 | |
| Not Available |
| Full Name | Tina Powers |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 915 6th Ave Ne Apt 301, Buffalo, Minnesota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073995411 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | R-228091-2 (Minnesota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Tina Powers, RN 915 6th Ave Ne Apt 301, Buffalo, MN 55313-1862 Ph: (763) 228-5658 | Tina Powers, RN 915 6th Ave Ne Apt 301, Buffalo, MN 55313-1862 Ph: (763) 228-5658 |
News Archive
Designed with the complete workflow in mind, Olympus has launched its cellVivo incubation system, for precise and ergonomic environmental control of advanced live cell imaging. Following the modular approach of the IX3 range of inverted microscope frames, cellVivo is based on a "one size fits all" concept, with adaptors for various IX73 and IX83 frame types, circumventing the need for multiple incubation systems for distinct microscope configurations.
Research focused on the regulation of the adult stem cells that line the gastrointestinal tract of Drosophila suggests new models for the study of Barrett's esophagus.
Wnt proteins are signaling molecules that play critical roles during embryonic development and in the regeneration of adult tissues. They bind to Frizzled and LRP family receptors on the cell surface, triggering a series of events that cause beta-catenin to enter the nucleus and activate transcription factors that control cell fate and cell proliferation. Mutations in components of the Wnt pathway lead to developmental defects and are common in cancer.
Women with dementia have fewer visits to the GP, receive less health monitoring and take more potentially harmful medication than men with dementia, new UCL (University College London) research reveals.
A clinical trial investigating the repurposed cancer drug nilotinib in people with Parkinson's disease finds that it is reasonably safe and well tolerated.
› Verified 6 days ago
Mark Roy Harstad, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 206 Spruce Ave Ne, Buffalo, MN 55313 Phone: 763-333-6075 | |
Vishal Gurung, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 25 1st Ave Ne Ste 100, Buffalo, MN 55313 Phone: 763-682-3005 | |
Kathleen Carpentier, RN-BC Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 25 1st Ave Ne, Buffalo, MN 55313 Phone: 763-682-3005 Fax: 763-682-3006 | |
John Friederichs Iii, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 25 1st Ave Ne Ste 100, Buffalo, MN 55313 Phone: 763-682-3005 | |
Josi Fjeld, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 25 1st Ave Ne Ste 100, Buffalo, MN 55313 Phone: 763-682-3005 | |
Chelsie Mauk, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 25 1st Ave Ne, Buffalo, MN 55313 Phone: 763-682-3005 |